Stent Thrombosis After Successful Sirolimus-Eluting Stent Implantation
暂无分享,去创建一个
David J Cohen | Brett G. Sylvia | A. Jeremias | A. Kirtane | Brian Bigelow | D. Cohen | D. Cutlip | K. Ho | J. Carrozza | Ajay J Kirtane | Donald E Cutlip | Allen Jeremias | L. Garcia | Brett Sylvia | Jonathan Bridges | Brian Bigelow | Duane S Pinto | Kalon K L Ho | Lawrence A Garcia | Joseph P Carrozza | Jonathan Bridges | D. Cohen | D. Cohen | D. Cohen
[1] William Wijns,et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS) , 2003, The Lancet.
[2] P. Serruys,et al. Angiographic Findings of the Multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): Sirolimus-Eluting Stents Inhibit Restenosis Irrespective of the Vessel Size , 2002, Circulation.
[3] Giuseppe Musumeci,et al. Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting Stent: Should We Be Cautious? , 2004, Circulation.
[4] D. Baim,et al. Stent Thrombosis in the Modern Era: A Pooled Analysis of Multicenter Coronary Stent Clinical Trials , 2001, Circulation.
[5] Jeffrey W Moses,et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. , 2003, The New England journal of medicine.
[6] M. Leon,et al. Drug-eluting stents and glycoprotein IIb/IIIa inhibitors: combination therapy for the future. , 2003, American heart journal.
[7] Patrick W Serruys,et al. Unrestricted Utilization of Sirolimus-Eluting Stents Compared With Conventional Bare Stent Implantation in the “Real World”: The R apamycin-E luting S tent E valuated A t R otterdam C ardiology H ospital (RESEARCH) Registry , 2004, Circulation.